US Patent 8754091 Inhibitors of bruton's tyrosine kinase
Patent 8754091 was granted and assigned to Pharmacyclics on June, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 4 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08754091 Inhibitors of bruton's tyrosine kinase US Patent 8754091 Inhibitors of bruton's tyrosine kinase
Infobox
Patent Number
0875409100
Patent Number
875409100
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087540910
Date of Patent
June 17, 2014
0Patent Application Number
135424400
Date Filed
July 5, 2012
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
087540910
Date of Patent
June 17, 2014
0Patent Application Number
135424400
Date Filed
July 5, 2012
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08754091 Inhibitors of bruton's tyrosine kinase
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08754091
Date of patent
June 17, 2014
Patent application number
13542440
Date Filed
July 5, 2012
Patent primary examiner
Find more entities like US Patent 8754091 Inhibitors of bruton's tyrosine kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
